282 related articles for article (PubMed ID: 25825163)
21. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
Duhamel G; Stachowiak J
Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
[TBL] [Abstract][Full Text] [Related]
22. Myelofibrosis in the myeloproliferative disorders.
Ellis JT; Peterson P
Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
[TBL] [Abstract][Full Text] [Related]
23. Fibrosis identified in the bone marrow biopsies of patients with essential thrombocythemia: its incidence and significance for the differential diagnostic considerations.
Marcinek J; Plank L; Szépe P; Balhárek T
Cesk Patol; 2008 Jul; 44(3):62-6. PubMed ID: 18783136
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres.
Kuter DJ; Bain B; Mufti G; Bagg A; Hasserjian RP
Br J Haematol; 2007 Nov; 139(3):351-62. PubMed ID: 17910625
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of myelofibrosis in chronic myeloproliferative disorders.
Yonekura S
Tokai J Exp Clin Med; 1987 Sep; 12(3):141-5. PubMed ID: 3331217
[No Abstract] [Full Text] [Related]
26. Myelofibrosis in chronic myeloproliferative disorders--dynamics and clinical impact.
Thiele J; Kvasnicka HM
Histol Histopathol; 2006 Dec; 21(12):1367-78. PubMed ID: 16977587
[TBL] [Abstract][Full Text] [Related]
27. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
28. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H
Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow hypervascularity in patients with myelofibrosis identified by infra-red thermography.
Baglin TP; Crocker J; Timmins A; Chandler S; Boughton BJ
Clin Lab Haematol; 1991; 13(4):341-8. PubMed ID: 1773587
[TBL] [Abstract][Full Text] [Related]
30. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].
Bedekovics J; Méhes G
Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557
[TBL] [Abstract][Full Text] [Related]
31. High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms.
Pozdnyakova O; Wu K; Patki A; Rodig SJ; Thiele J; Hasserjian RP
Mod Pathol; 2014 Nov; 27(11):1447-54. PubMed ID: 24762543
[TBL] [Abstract][Full Text] [Related]
32. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
33. [Mechanism of myelofibrosis in chronic myeloproliferative disorders].
Nagao T; Yonekura S
Rinsho Ketsueki; 1988 Jul; 29(7):983-8. PubMed ID: 2846914
[No Abstract] [Full Text] [Related]
34. What is pre-fibrotic myelofibrosis and how should it be managed in 2018?
Curto-Garcia N; Ianotto JC; Harrison CN
Br J Haematol; 2018 Oct; 183(1):23-34. PubMed ID: 30328618
[TBL] [Abstract][Full Text] [Related]
35. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
36. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
Thiele J; Kvasnicka HM
Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.
Gianelli U; Fiori S; Cattaneo D; Bossi A; Cortinovis I; Bonometti A; Ercoli G; Bucelli C; Orofino N; Bulfamante G; Iurlo A
Histopathology; 2017 Dec; 71(6):897-908. PubMed ID: 28710830
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of platelet-derived growth factor (PDGF) and PDGF receptor-alpha is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis.
Bock O; Loch G; Büsche G; von Wasielewski R; Schlué J; Kreipe H
Haematologica; 2005 Jan; 90(1):133-4. PubMed ID: 15642683
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: a concise update.
Thiele J; Kvasnicka HM; Fischer R; Diehl V
Leuk Lymphoma; 1997 Feb; 24(5-6):463-81. PubMed ID: 9086437
[TBL] [Abstract][Full Text] [Related]
40. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
Pizzi M; Gergis U; Chaviano F; Orazi A
Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
